Cochrane · systematic review · CD013667

Interventions for self‐harm in children and adolescents

Witt, KG, Hetrick, SE, Rajaram, G, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 25%Low 1 · 25%Moderate 1 · 25%High 1 · 25%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents

Population: self‐harm in children and adolescents (up to 18 years or age)
1 question
OutcomeEffectEvidenceStatus / GRADE
Repetition of SH by post‐intervention
Comparison 1: Individual CBT‐based psychotherapy vs TAU or other comparator
OR 0.93 [0.12, 7.24]2 studies · 51 participantsLow
Downgraded: risk of bias

Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents

Population: self‐harm in children and adolescents (up to 18 years or age)
1 question
OutcomeEffectEvidenceStatus / GRADE
Repetition of SH at post‐intervention
Comparison 2: DBT‐A vs TAU or another comparator
OR 0.46 [0.26, 0.82]4 studies · 270 participantsHigh

Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents

Population: self‐harm in children and adolescents (up to 18 years or age)
1 question
OutcomeEffectEvidenceStatus / GRADE
Repetition of SH at post‐intervention
Comparison 3: MBT‐A vs TAU or another comparator
OR 0.7 [0.06, 8.46]2 studies · 85 participantsVery low
Downgraded: risk of bias

Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents

Population: self‐harm in children and adolescents (up to 18 years or age)
1 question
OutcomeEffectEvidenceStatus / GRADE
Repetition of SH at post‐intervention
Comparison 7: Family therapy vs placebo
OR 1 [0.49, 2.07]2 studies · 191 participantsModerate